An Evaluation of LY007 Cell Injection for r/r B-NHL

NCT06279611 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B-NHL

Interventions

DRUG: LY007

Sponsor

Shanghai Longyao Biotechnology Inc., Ltd.

Collaborators

[object Object]
[object Object]